• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Future Infectious Disease Nucleic Acid Testing Product Image

Future Infectious Disease Nucleic Acid Testing

  • Published: February 2012
  • 360 pages
  • Venture Planning Group (VPG)

This 360-page report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.

Contains 360 pages and 20 tables.

1. Overview

2. Major Infectious Diseases

AIDS
- Structure and Composition
- Classification
- AIDS Origins
- Animal Lentivirus Systems
- Virus Receptors
- HIV Infections in Humans
-- Pathogenesis and Pathology
- CD4T Lymphocytes and Memory Cells
- Monocytes and Macrophages
- Lymphoid Organs
- Neural Cells
- Viral Coinfections
-- Clinical Findings
- Plasma Viral Load
- Pediatric AIDS
-- Neurologic Disease
-- Opportunistic Infections
-- Cancer
- Immunity
-- Virus Isolation
-- Serology
-- Viral Nucleic Acid/Antigen Detection
- Epidemiology
-- Worldwide Spread of AIDS
-- United States
-- Routes of Transmission
- DNA Probes
-- Overview
-- Quantitative PCR
-- In Situ PCR
-- Needed Improvements
- Viral Load/Drug Resistance Testing
- Genotype and Phenotype Testing
- Blood Banking Considerations
-- Adenovirus
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Adeno-Associated Viruses (AAV)
-- Anthrax/Bacillus Anthracis
- Background
- Diagnostic Tests
- Vaccines and Drugs
-- Babesiosis
- Background
-- BEA and Other Bartonella Diseases
- Background
- Diagnostic Tests
- Vaccines and Drugs
-- Chagas Disease
- Background
- Campylobacter
- Background
- Diagnostic Tests
-- Culture Identification
- Vaccines and Drugs
-- Chlamydia
- Background
-- Chlamydia psittaci
-- Chlmaydia pneumoniae
-- Chlamydia trachomatis
- Diagnostic Tests
- Vaccines and Drugs
-- Creutzfeldt-Jakob’s Disease
- Background
- Blood Transmission
- Diagnostic Tests
- Major Commercial and Academic Players
-- Bayer
-- Disease Sciences/Bio Tec Global
-- Imperial College School of Medicine
-- Ortho-Clinical Diagnostics
-- Pall
-- ProMetic Life Sciences
-- Proteome Sciences/Idexx
-- Q-One Biotech
-- Serono
-- U.S. Agricultural Research Service
- Drugs
- Vaccines
-- Cytomegalovirus
- Background
-- Chorioretinitis
-- Gastrointestinal
- Central Nervous System Disease
- Diagnostic Tests
- Vaccines and Drugs
-- Ebola Virus
- Background
-- Epidemiology
-- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
-- EchoVirus
- Background
-- Acute Aseptic Meningitisis
-- Encephalitis
-- Exanthems
-- Respiratory Disease
-- Myopericarditis
-- Neonatal Infections
- Diagnostic Tests
- Vaccines and Drugs
-- Encephalitis
- Background
- Diagnostic Tests
- Vaccines and Drugs
-- Enteroviruses
- Background
- Diagnostic Tests
-- Viral Isolation and Identification
-- Antibody Tests
- Vaccines and Drugs
- Epstein-Barr Virus
- Background
- Diagnostic Tests
- Vaccines and Drugs
-- Gonorrhea
- Background
- Diagnostic Tests
- Vaccines and Drugs
-- Hepatitis
- Hepatitis A
- Hepatitis B

Structure and Composition
- Replication
- Hepatitis C
- Hepatitis D (Delta)
- Hepatitis E
- Hepatitis G
- Hepatitis Infections Pathology
- Clinical Findings
- Laboratory Tests
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D
- Hepatitis E
- Virus-Host Immune Reactions
- Epidemiology
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D (Delta)
- Vaccines and Drugs
-- Herpes Simplex Virus
- Background
- Diagnostic Tests
- Vaccines and Drugs
-- Legionella
- Background
- Diagnostic Tests
- Vaccines and Drugs
-- Lyme Disease
- Background
- Clinical Description
- Clinical Case Definition
- Laboratory Criteria for Diagnosis
- Case Classification
- Diagnostic Tests
- Vaccines and Drugs
-- Malaria
- Mycoplasma
- Background
- Ureaplasma Urealyticum & MycoplasmaHominis
- Diagnostic Tests
- Vaccines and Drugs
-- Papillomaviruses/HPV
- Background
- HPV in Cancer
- Cervical Neoplasm
- Diagnostic Tests
- Vaccines and Drugs
- Prevention
-- Parvovirus B19
- Background
- Microbiology
- Epidemiology
- Clinical Syndromes
- Erythema Infectiosum (Slapped Cheek)
- Adult Polyarthropathy
- Transient Aplastic Crisis
- Transient Pancytopenia
- Red Cell Aplasia in Immunocompromised
- Perinatal Infections
- Diagnostic Test
- Vaccines and Drugs
- Pneumonia
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Polyomaviruses
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Salmonellosis
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Shigellosis
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Streptococci
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Group A Streptococci
- Group B Streptococci
- Toxoplasmosis
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Tuberculosis
- Background
- Diagnostic Tests
- Microscopic Characteristics
- Cultural Characteristics
- Skin Tests
- MDRTB
- Vaccines and Drugs
- West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
- Yersinia
- Background
- Diagnostic Tests
- Vaccines and Drugs

3. Antibiotic Susceptibility

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos